'Patenting in the public interest:' Administration of insulin patents by the University of Toronto

History and Technology

Volumn 24, Issue 2, 2008, Pages 153-171

  Cassier, Maurice ^a   Sinding, Christiane ^a  

^a NONE

Author keywords

Drug regulation; Insulin; Medical ethics; Patent pool

Indexed keywords

EID: 40749128797     PISSN: 07341512     EISSN: 14772620     Source Type: Journal    
DOI: 10.1080/07341510701810948     Document Type: Article

References (22)

1. Abraham, John (1995) Science, Politics and the Pharmaceutical Industry. Controversy and Bias in Drug Regulation, St. Martin's Press, London
2. American Medical Association (1939) Conference on Medical Patents. Journal of the American Association of Medicine, 113:4, pp. 327-335.
3. Apple, Rima (1989) Patenting University Research. Harry Steenbock and the Wisconsin Alumni Research Foundation. Isis, 80, pp. 375-394.
4. Bliss, Michael (1982) The Discovery of Insulin, University of Chicago Press, Chicago
5. Cassier, Maurice (2004) Brevet et santé., Dictionnaire de la pensée médicale, PUF, Paris
6. Cassier, Maurice Genome Patents Nowadays and Pharmaceutical Patents in the 19th Century: A Parallel. International Conference, 'Technological Policy and Innovation: Economic and historical perspectives' Paris pp. 1-22.
7. Cassier, Maurice and Correa, Marilena (2003) Patent, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs. Economics of Aids and Access to HIV/AIDS Care in Developing Countries, Ed. ANRS, Paris
8. Conolly, Arthur (1937) Should Medical Inventions be Patented?. Science, 86, pp. 383-387.
9. Gidney, R. D. and Millar, P. J. (1994) The Reorientation of Medical Education in Late Nineteenth-Century Ontario: The Proprietary Medical Schools and the Founding of the Faculty of Medicine at the University of Toronto. Joural of the History of Medicine and Allied Sciences, 49, pp. 52-78.
10. Liebenau, Jonathan (1989) The MRC and the Pharmaceutical Industry: The Model of Insulin. Historical Perspectives on the Role of the MRC, Essays in the History of the Medical Research Council of the United Kingdom and its Predecessors, the Medical Research Committee, 1913-1953, Oxford University Press, Oxford
11. Malissard, Pierrick (1999) Université du Québec à Montréal
12. (1939) Manufacturers' point of view on medical patents in relation to public welfare. Journal of the American Association of Medicine, 113:4, pp. 419-427.
13. Merges, Robert (1998) University of California at Berkeley School of Law
14. Rasmussen, Nicolas (2002) pp. 1-40. Max Planck Institute for the History of Science, Berlin
15. Rasmussen, Nicolas (2004) The Moral Economy of the Drug Company Medical Scientist Collaboration in Interwar America. Social Studies of Science, 34, pp. 161-185.
16. Simon, Jonathan Adrenalin, Epinephrin or Suprarenin? Identifying the true hypertensive principle. Unpublished paper presented at Conference on 'Drug Trajectories: Historical Studies of Biology, Medicine, and Industry,' Max Planck Institute for the History of Science Berlin pp. 1-11.
17. Sinding, Christiane (2002) Making the Unit of Insulin: Standards, Clinical Work and Industry. Bulletin of the History of Medicine, 76, pp. 231-270.
18. Swann, John Paul (1988) Academic Scientists and the Pharmaceutical Industry: Cooperative Research in twentieth-century America, Johns Hopkins University Press, Baltimore
19. Temin, Peter (1980) Taking your Medicine. Drug Regulation in the United States, Harvard University Press, Cambridge, Mass.
20. Weiner, Charles (1987) Patenting and Academic Research: Historical Case Studies. Science, Technology and Human Values, 12, pp. 50-62.
21. Williams, Michael J. (1993) J.J.R. Macleod: The Codiscoverer of Insulin. Proceedings of the Royal College of Physicians of Edinburgh, 23, pp. 1-125.
22. Young, James Harvey (1961) The Toadstool Millionaires: A Social History of Patent Medicines in America before Federal Regulation, Princeton University Press, Princeton, NJ